A snapshot of the challenges health-tech startups will face in a post-Covid world, and how they can be tackled.
Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how R&D, regulatory and commercial activities have globally bolstered the technological promise of Cancer CART therapy, and outlines its progress and adoption in India
Now that Covid-19 has made its ugly presence felt in every sphere, including business and economy, a huge portion of upcoming businesses shall have to rely on small industries and other forms of entrepreneurship.